SAM-Cancellation Notice.pdf
PDF 147 KB Posted
- Attached to
- Post-Market Bioequivalence (BE) Studies
- Solicitation number
- Not on record
About this file
This document is an Amendment (Number: 2) for a U.S. Food and Drug Administration (FDA) solicitation completely cancelling a previously issued contract opportunity. The original solicitation (Number: 75F40125R00097) was for "Post-market Bioequivalence of Generic Drug Products IDIQ" and is being terminated effective 11/21/2025 because the government no longer requires the described supplies/services.
The amendment, issued by Contracting Officer Ian Weiss and Contract Specialist Telisha Wilson, explicitly states that no proposals will be accepted or evaluated, any previously submitted proposals will not be opened or considered, and offerors should immediately cease all proposal preparation work. The cancellation has been posted to SAM.gov in compliance with Federal Acquisition Regulation (FAR) public notification requirements, and potential vendors are directed to contact the Contracting Officer with any questions.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
FDA/OAGS/DAO/SSB
Amendment Number: 2
Original Solicitation Number: 75F40125R00097 (121683) Title: Post-market Bioequivalence of Generic Drug Products IDIQ Amendment Date: 11/21/2025 Contracting Officer: Ian Weiss Contract Specialist: Telisha Wilson
AMENDMENT TYPE: CANCELLATION
This amendment CANCELS the above-referenced solicitation in its entirety.
Reason for Cancellation:
• The Government no longer has a requirement for the supplies/services described in this solicitation.
Effective Date: 11/21/2025
This cancellation is effective immediately upon posting of this amendment.
Impact on Proposals:
• No proposals will be accepted or evaluated for this solicitation
• Any proposals already submitted will not be opened or considered
• Offerors should cease all work related to proposal preparation for this requirement
Questions:
Direct any questions regarding this cancellation to the Contracting Officer listed above.
Contracting Officer Signature: Ian Weiss; ian.weiss@fda.hhs.gov Contract Specialist: Telisha Wilson; Telisha.wilson@fda.hhs.gov
Date: 11/21/2025
This amendment has been posted to SAM.gov in accordance with FAR requirements for public notification.
| Amendment Number: 2 |
| AMENDMENT TYPE: CANCELLATION |
| Reason for Cancellation: |
| Effective Date: 11/21/2025 |
| Impact on Proposals: |
| Questions: |
File details come from the government source that posted it. Updated .